Cargando…
Structure of the NDH-2 – HQNO inhibited complex provides molecular insight into quinone-binding site inhibitors
Type II NADH:quinone oxidoreductase (NDH-2) is a proposed drug-target of major pathogenic microorganisms such as Mycobacterium tuberculosis and Plasmodium falciparum. Many NDH-2 inhibitors have been identified, but rational drug development is impeded by the lack of information regarding their mode...
Autores principales: | Petri, Jessica, Shimaki, Yosuke, Jiao, Wanting, Bridges, Hannah R., Russell, Euan R., Parker, Emily J., Aragão, David, Cook, Gregory M., Nakatani, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Pub. Co
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167311/ https://www.ncbi.nlm.nih.gov/pubmed/29621505 http://dx.doi.org/10.1016/j.bbabio.2018.03.014 |
Ejemplares similares
-
The mechanism of catalysis by type-II NADH:quinone oxidoreductases
por: Blaza, James N., et al.
Publicado: (2017) -
Effect of the pseudomonas metabolites HQNO on the Toxoplasma gondii RH strain in vitro and in vivo
por: Mo, Jiao, et al.
Publicado: (2023) -
Synthesis and biological activity of methylated derivatives of the Pseudomonas metabolites HHQ, HQNO and PQS
por: Thierbach, Sven, et al.
Publicado: (2019) -
Identification, Design
and Biological Evaluation
of Heterocyclic Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)
por: Leung, Suet C., et al.
Publicado: (2012) -
Identification, Design
and Biological Evaluation
of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)
por: Pidathala, Chandrakala, et al.
Publicado: (2012)